A new insight into RecA filament regulation by RecX from the analysis of conformation-specific interactions

  1. Aleksandr Alekseev  Is a corresponding author
  2. Georgii Pobegalov  Is a corresponding author
  3. Natalia Morozova
  4. Alexey Vedyaykin
  5. Galina Cherevatenko
  6. Alexander Yakimov
  7. Dmitry Baitin
  8. Mikhail Khodorkovskii
  1. Peter the Great St. Petersburg Polytechnic University, Russian Federation
  2. Kurchatov Institute, Russian Federation

Abstract

RecA protein mediates homologous recombination repair in bacteria through assembly of long helical filaments on single-stranded DNA (ssDNA) in an ATP dependent manner. RecX, an important negative regulator of RecA, is known to inhibit RecA activity by stimulating the disassembly of RecA nucleoprotein filaments. Here we use a single-molecule approach to address the regulation of (E. coli) RecA-ssDNA filaments by RecX (E. coli) within the framework of distinct conformational states of RecA-ssDNA filament. Our findings revealed that RecX effectively binds the inactive conformation of RecA-ssDNA filaments and slows down the transition to the active state. Results of this work provide new mechanistic insights into the RecX-RecA interactions and highlight the importance of conformational transitions of RecA filaments as an additional level of regulation of its biological activity.

Data availability

Source data files were provided for Figures 1, 2, 3, 4, 5 and Figures supplements.Raw fluorescent images of DNA tether were provided for Figure 4C as Zip file.

Article and author information

Author details

  1. Aleksandr Alekseev

    Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russian Federation
    For correspondence
    a.alekseev@nanobio.spbstu.ru
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4371-265X
  2. Georgii Pobegalov

    Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russian Federation
    For correspondence
    george.pobegalov@nanobio.spbstu.ru
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0836-0732
  3. Natalia Morozova

    Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russian Federation
    Competing interests
    The authors declare that no competing interests exist.
  4. Alexey Vedyaykin

    Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russian Federation
    Competing interests
    The authors declare that no competing interests exist.
  5. Galina Cherevatenko

    Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russian Federation
    Competing interests
    The authors declare that no competing interests exist.
  6. Alexander Yakimov

    Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russian Federation
    Competing interests
    The authors declare that no competing interests exist.
  7. Dmitry Baitin

    Kurchatov Institute, St. Petersburg, Russian Federation
    Competing interests
    The authors declare that no competing interests exist.
  8. Mikhail Khodorkovskii

    Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russian Federation
    Competing interests
    The authors declare that no competing interests exist.

Funding

Russian Science Foundation (19-74-10049)

  • Aleksandr Alekseev
  • Georgii Pobegalov
  • Alexander Yakimov

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Alekseev et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 897
    views
  • 232
    downloads
  • 7
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Aleksandr Alekseev
  2. Georgii Pobegalov
  3. Natalia Morozova
  4. Alexey Vedyaykin
  5. Galina Cherevatenko
  6. Alexander Yakimov
  7. Dmitry Baitin
  8. Mikhail Khodorkovskii
(2022)
A new insight into RecA filament regulation by RecX from the analysis of conformation-specific interactions
eLife 11:e78409.
https://doi.org/10.7554/eLife.78409

Share this article

https://doi.org/10.7554/eLife.78409

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Marina Dajka, Tobias Rath ... Benesh Joseph
    Research Article

    Lipopolysaccharides (LPS) confer resistance against harsh conditions, including antibiotics, in Gram-negative bacteria. The lipopolysaccharide transport (Lpt) complex, consisting of seven proteins (A-G), exports LPS across the cellular envelope. LptB2FG forms an ATP-binding cassette transporter that transfers LPS to LptC. How LptB2FG couples ATP binding and hydrolysis with LPS transport to LptC remains unclear. We observed the conformational heterogeneity of LptB2FG and LptB2FGC in micelles and/or proteoliposomes using pulsed dipolar electron spin resonance spectroscopy. Additionally, we monitored LPS binding and release using laser-induced liquid bead ion desorption mass spectrometry. The β-jellyroll domain of LptF stably interacts with the LptG and LptC β-jellyrolls in both the apo and vanadate-trapped states. ATP binding at the cytoplasmic side is allosterically coupled to the selective opening of the periplasmic LptF β-jellyroll domain. In LptB2FG, ATP binding closes the nucleotide binding domains, causing a collapse of the first lateral gate as observed in structures. However, the second lateral gate, which forms the putative entry site for LPS, exhibits a heterogeneous conformation. LptC binding limits the flexibility of this gate to two conformations, likely representing the helix of LptC as either released from or inserted into the transmembrane domains. Our results reveal the regulation of the LPS entry gate through the dynamic behavior of the LptC transmembrane helix, while its β-jellyroll domain is anchored in the periplasm. This, combined with long-range ATP-dependent allosteric gating of the LptF β-jellyroll domain, may ensure efficient and unidirectional transport of LPS across the periplasm.

    1. Structural Biology and Molecular Biophysics
    Shristi Pawnikar, Brenda S Magenheimer ... Yinglong Miao
    Research Article

    Polycystin-1 (PC1) is the protein product of the PKD1 gene whose mutation causes autosomal dominant Polycystic Kidney Disease (ADPKD). PC1 is an atypical G protein-coupled receptor (GPCR) with an autocatalytic GAIN domain that cleaves PC1 into extracellular N-terminal and membrane-embedded C-terminal (CTF) fragments. Recently, activation of PC1 CTF signaling was shown to be regulated by a stalk tethered agonist (TA), resembling the mechanism observed for adhesion GPCRs. Here, synthetic peptides of the first 9- (p9), 17- (p17), and 21-residues (p21) of the PC1 stalk TA were shown to re-activate signaling by a stalkless CTF mutant in human cell culture assays. Novel Peptide Gaussian accelerated molecular dynamics (Pep-GaMD) simulations elucidated binding conformations of p9, p17, and p21 and revealed multiple specific binding regions to the stalkless CTF. Peptide agonists binding to the TOP domain of PC1 induced close TOP-putative pore loop interactions, a characteristic feature of stalk TA-mediated PC1 CTF activation. Additional sequence coevolution analyses showed the peptide binding regions were consistent with covarying residue pairs identified between the TOP domain and the stalk TA. These insights into the structural dynamic mechanism of PC1 activation by TA peptide agonists provide an in-depth understanding that will facilitate the development of therapeutics targeting PC1 for ADPKD treatment.